Literature DB >> 14533489

Elaboration of enzyme immunoassay based on recombinant antigens and intended for diagnostics of syphilis.

N Rostopira1, L Tkáciková, G Rayevska, V Pylypenko, I Mikula, M Spivak.   

Abstract

Enzyme immunoassay (EIA) using recombinant antigens for the detection of Treponema pallidum-specific antibodies in sera of syphilis patients was developed. Four low-molar-mass Treponema antigens (Tp15, Tp17, TmpA, Tp47) were investigated; 17- and 47-kDa proteins were demonstrated as immunodominant as they permitted to obtain the most sensitive EIA. Using a mixture of these proteins a 3rd-generation-EIA kit Dia-Syph was constructed, its sensitivity being 99.4% during tests of 165 sera of syphilitic patients. No false result was obtained on the commercial panel PSS01 (BBI, USA). The specificity of the elaborated test system (99.7%) was determined on 295 sera.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14533489     DOI: 10.1007/BF02931339

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.629


  10 in total

Review 1.  Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

Authors:  A E Singh; B Romanowski
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  The genome sequence of Treponema pallidum, the syphilis spirochete: will clinicians benefit?

Authors:  Steven J. Norris; George M. Weinstock
Journal:  Curr Opin Infect Dis       Date:  2000-02       Impact factor: 4.915

3.  Western immunoblotting with five Treponema pallidum recombinant antigens for serologic diagnosis of syphilis.

Authors:  V Sambri; A Marangoni; C Eyer; C Reichhuber; E Soutschek; M Negosanti; A D'Antuono; R Cevenini
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 4.  Syphilis. Serology.

Authors:  H Young
Journal:  Dermatol Clin       Date:  1998-10       Impact factor: 3.478

5.  Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for control.

Authors:  L Tichonova; K Borisenko; H Ward; A Meheus; A Gromyko; A Renton
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Differences in anti-protein A activity among IgG subgroups.

Authors:  G Kronvall; R C Williams
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

8.  Novel recombinant-antigen enzyme immunoassay for serological diagnosis of syphilis.

Authors:  H Young; A Moyes; L Seagar; A McMillan
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

9.  Recombinant antigen-based enzyme immunoassay for screening of Treponema pallidum antibodies in blood bank routine.

Authors:  M Zrein; I Maure; F Boursier; L Soufflet
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  Complete genome sequence of Treponema pallidum, the syphilis spirochete.

Authors:  C M Fraser; S J Norris; G M Weinstock; O White; G G Sutton; R Dodson; M Gwinn; E K Hickey; R Clayton; K A Ketchum; E Sodergren; J M Hardham; M P McLeod; S Salzberg; J Peterson; H Khalak; D Richardson; J K Howell; M Chidambaram; T Utterback; L McDonald; P Artiach; C Bowman; M D Cotton; C Fujii; S Garland; B Hatch; K Horst; K Roberts; M Sandusky; J Weidman; H O Smith; J C Venter
Journal:  Science       Date:  1998-07-17       Impact factor: 47.728

  10 in total
  2 in total

1.  Europium nanoparticle-based high performing immunoassay for the screening of treponemal antibodies.

Authors:  Sheikh M Talha; Jukka Hytönen; Adam Westhorpe; Sushil Kumar; Navin Khanna; Kim Pettersson
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

2.  Performance of Treponema pallidum recombinant proteins in the serological diagnosis of syphilis.

Authors:  Ângelo Antônio Oliveira Silva; Ueriton Dias de Oliveira; Larissa de Carvalho Medrado Vasconcelos; Leonardo Foti; Leonardo Maia Leony; Ramona Tavares Daltro; Amanda Leitolis; Fernanda Washington de Mendonça Lima; Marco Aurélio Krieger; Nilson Ivo Tonin Zanchin; Fred Luciano Neves Santos
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.